Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from BioNxt Solutions ( (TSE:BNXT) ) is now available.
BioNxt Solutions Inc. has successfully closed the final tranche of its non-brokered private placement of unsecured convertible debentures, raising a total of $3,000,000. The funds raised will be allocated towards product development, intellectual property filings, and general working capital, potentially enhancing the company’s market positioning and operational capabilities.
More about BioNxt Solutions
BioNxt Solutions Inc. operates in the biotechnology industry and focuses on product development, intellectual property filings, and general working capital. The company is listed on multiple exchanges, including the Canadian Securities Exchange, and is involved in financing activities to support its operations.
YTD Price Performance: -10.36%
Average Trading Volume: 10,336
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $32.39M
Find detailed analytics on BNXT stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue